Related Experiment Video
Updated: May 29, 2026
06:08
A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
Outcome of surgery for primary hyperaldosteronism
Jens Waldmann1, Lisa Maurer, Julia Holler
1Department of Surgery, University Hospital Giessen and Marburg, Baldingerstraße 1, 35043, Marburg, Germany. jwaldman@med.uni-marburg.de
World Journal of Surgery
|September 2, 2011
Summary
Laparoscopic adrenalectomy resolves hypertension in 74% of primary hyperaldosteronism patients, though full resolution may take over a year. Shorter hypertension duration and fewer medications predict better outcomes.
Area of Science:
- Endocrinology
- Surgical Oncology
- Nephrology
Background:
- Primary hyperaldosteronism (PHA) is a common cause of secondary hypertension.
- Laparoscopic adrenalectomy is a potential surgical cure for PHA associated with unilateral adenoma.
Purpose of the Study:
- To identify clinical parameters predicting hypertension resolution after laparoscopic adrenalectomy for PHA.
- To evaluate the long-term outcomes of laparoscopic adrenalectomy in PHA patients.
Main Methods:
- Retrospective review of patients with PHA who underwent laparoscopic adrenalectomy between 1993 and 2009.
- Analysis of clinical parameters and hormone levels, including univariate and multivariate analysis.
Main Results:
- 74% of patients experienced hypertension resolution or improvement post-surgery.
- Independent predictors of hypertension resolution included shorter hypertension duration (<6 years), fewer antihypertensive drugs (<3), and lower serum creatinine (<1.3 mmol/l).
- Hypertension resolution was observed in 57% of patients at a mean follow-up of 49 months, with 10 patients requiring over 12 months for resolution.
Conclusions:
- Laparoscopic adrenalectomy is effective in managing hypertension in PHA, with resolution occurring in approximately 50% of cases.
- Hypertension duration, number of antihypertensive drugs, and serum creatinine levels are crucial factors influencing surgical outcomes.
- Coexistent hyperplasia does not appear to impact the resolution of hypertension post-adrenalectomy.
Related Concept Videos
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
01:27Adrenal Gland Disorders
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:26Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
01:33Hormonal Regulation
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
01:25Antihypertensive Drugs: Direct Renin Inhibitors
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...